Who are we?
Linnaeus Healthcare is a private company, manufacturing and marketing high quality organic cannabidiol (CBD) products and ecologically sustainable algae derived omega-3 essential fatty acids. The company is named after Carl Linnaeus, who was one of the most acclaimed scientists in Europe in the mid-late 18th century. Our Team is supported by experts in medicine, plant medicine, human nutrition, as well as novel food & food-supplement law.
At Linnaeus Healthcare, our commitment is to our customers, enabling them to achieve and maintain increased levels of health and wellbeing. We aim to educate and support people on their own journey towards better health, not only by providing high quality products that are affordable, but also unbiased scientific facts and information on relevant subjects, which will enable people to make more informed choices about their health and supporting measures they may wish to take. See: Useful & Research button on Home Page.
At present, there are no permitted health claims for CBD products, apart from the legally authorised, clinically tested products - Sativex & Epidiolex, from G W Pharmaceuticals plc. This will change however from March 2021, when European and UK legislation come into force; this means that all CBD products that are classified as Food Supplements will have to be officially approved. This is not the same as Market Authorisation, but is a positive step forward, allowing the consumer to choose and purchase CBD products that are of reliable quality.
Carl Linnaeus was an 18th Century Swedish botanist, zoologist and physician who is known as the "father" of modern taxonomy, creating a system of classification by giving 2 names to living organisms, the first name he called the genus and the second name, the species. He was the first person to classify Cannabis as a genus in his Species Plantarum in 1753 with a single species being called Sativa. Hence the name Cannabis Sativa, which is one of the oldest known cultivated plants - being six times as strong as cotton, with a long history of medical use, being 200 times more powerful than aspirin. It’s common name was unsurprisingly common hemp (now called industrial hemp), a use according to historical records, dating from 1548.
Linnaeus considered Cannabis Indica and later Cannabis Ruderalis as merely varieties or strains of Cannabis Sativa, however they are now classified as a sub-species. To honour the work of Linnaeus, the letter L is usually put after the names in Latin, of the plants and animals he himself classified.
The consensus amongst modern international botanical organisations, is that all new varieties or strains (whatever their local name) are all cannabis or hemp and derived from Cannabis Sativa L. To understand this classification another way, look at the tomato plant which Linnaeus also first classified, as being a single genus Solanum with many varieties or strains, of the species Lycopersicum – and many varieties you can buy in the shops today.
The critical issue from a medicinal & legal viewpoint is; how much THC does a particular variety of hemp contain? Industrial or common hemp varieties, to be legal, contains less than 0.3mg THC. Other varieties of cannabis or hemp contain considerable levels of THC, which then put them into a narcotic or Class A Drug (UK) category.
From The Team here at Linnaeus Healthcare
we wish you all well and keep safe.